Global Blood Coagulants Market Growth 2025-2031

October 2025 | 97 pages | ID: G449339F537EN
LP Information

Abstracts

The global Blood Coagulants market size is predicted to grow from US$ 472 million in 2025 to US$ 698 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the ?Blood Coagulants Industry Forecast? looks at past sales and reviews total world Blood Coagulants sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Coagulants sales for 2025 through 2031. With Blood Coagulants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Coagulants industry.

This Insight Report provides a comprehensive analysis of the global Blood Coagulants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Coagulants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood Coagulants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Coagulants and breaks down the forecast by Type, by Sale Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Coagulants.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Coagulants market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Recombinant Coagulation Factor
• Plasma Coagulation Factor

Segmentation by Sale Channel:

• Hospital
• Pharmacy
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Bayer
• Novo Nordisk
• Takeda
• SOBI
• Octapharma
• CSL

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Coagulants market?
What factors are driving Blood Coagulants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Coagulants market opportunities vary by end market size?
How does Blood Coagulants break out by Type, by Sale Channel?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Blood Coagulants Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Blood Coagulants by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Blood Coagulants by Country/Region, 2020, 2024 & 2031
2.2 Blood Coagulants Segment by Type
  2.2.1 Recombinant Coagulation Factor
  2.2.2 Plasma Coagulation Factor
2.3 Blood Coagulants Sales by Type
  2.3.1 Global Blood Coagulants Sales Market Share by Type (2020-2025)
  2.3.2 Global Blood Coagulants Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Blood Coagulants Sale Price by Type (2020-2025)
2.4 Blood Coagulants Segment by Sale Channel
  2.4.1 Hospital
  2.4.2 Pharmacy
  2.4.3 Other
2.5 Blood Coagulants Sales by Sale Channel
  2.5.1 Global Blood Coagulants Sale Market Share by Sale Channel (2020-2025)
  2.5.2 Global Blood Coagulants Revenue and Market Share by Sale Channel (2020-2025)
  2.5.3 Global Blood Coagulants Sale Price by Sale Channel (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Blood Coagulants Breakdown Data by Company
  3.1.1 Global Blood Coagulants Annual Sales by Company (2020-2025)
  3.1.2 Global Blood Coagulants Sales Market Share by Company (2020-2025)
3.2 Global Blood Coagulants Annual Revenue by Company (2020-2025)
  3.2.1 Global Blood Coagulants Revenue by Company (2020-2025)
  3.2.2 Global Blood Coagulants Revenue Market Share by Company (2020-2025)
3.3 Global Blood Coagulants Sale Price by Company
3.4 Key Manufacturers Blood Coagulants Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Blood Coagulants Product Location Distribution
  3.4.2 Players Blood Coagulants Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BLOOD COAGULANTS BY GEOGRAPHIC REGION

4.1 World Historic Blood Coagulants Market Size by Geographic Region (2020-2025)
  4.1.1 Global Blood Coagulants Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Blood Coagulants Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Blood Coagulants Market Size by Country/Region (2020-2025)
  4.2.1 Global Blood Coagulants Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Blood Coagulants Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blood Coagulants Sales Growth
4.4 APAC Blood Coagulants Sales Growth
4.5 Europe Blood Coagulants Sales Growth
4.6 Middle East & Africa Blood Coagulants Sales Growth

5 AMERICAS

5.1 Americas Blood Coagulants Sales by Country
  5.1.1 Americas Blood Coagulants Sales by Country (2020-2025)
  5.1.2 Americas Blood Coagulants Revenue by Country (2020-2025)
5.2 Americas Blood Coagulants Sales by Type (2020-2025)
5.3 Americas Blood Coagulants Sales by Sale Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Blood Coagulants Sales by Region
  6.1.1 APAC Blood Coagulants Sales by Region (2020-2025)
  6.1.2 APAC Blood Coagulants Revenue by Region (2020-2025)
6.2 APAC Blood Coagulants Sales by Type (2020-2025)
6.3 APAC Blood Coagulants Sales by Sale Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Blood Coagulants by Country
  7.1.1 Europe Blood Coagulants Sales by Country (2020-2025)
  7.1.2 Europe Blood Coagulants Revenue by Country (2020-2025)
7.2 Europe Blood Coagulants Sales by Type (2020-2025)
7.3 Europe Blood Coagulants Sales by Sale Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Blood Coagulants by Country
  8.1.1 Middle East & Africa Blood Coagulants Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Blood Coagulants Revenue by Country (2020-2025)
8.2 Middle East & Africa Blood Coagulants Sales by Type (2020-2025)
8.3 Middle East & Africa Blood Coagulants Sales by Sale Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Coagulants
10.3 Manufacturing Process Analysis of Blood Coagulants
10.4 Industry Chain Structure of Blood Coagulants

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Blood Coagulants Distributors
11.3 Blood Coagulants Customer

12 WORLD FORECAST REVIEW FOR BLOOD COAGULANTS BY GEOGRAPHIC REGION

12.1 Global Blood Coagulants Market Size Forecast by Region
  12.1.1 Global Blood Coagulants Forecast by Region (2026-2031)
  12.1.2 Global Blood Coagulants Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Blood Coagulants Forecast by Type (2026-2031)
12.7 Global Blood Coagulants Forecast by Sale Channel (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Blood Coagulants Product Portfolios and Specifications
  13.1.3 Pfizer Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 Bayer
  13.2.1 Bayer Company Information
  13.2.2 Bayer Blood Coagulants Product Portfolios and Specifications
  13.2.3 Bayer Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bayer Main Business Overview
  13.2.5 Bayer Latest Developments
13.3 Novo Nordisk
  13.3.1 Novo Nordisk Company Information
  13.3.2 Novo Nordisk Blood Coagulants Product Portfolios and Specifications
  13.3.3 Novo Nordisk Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Novo Nordisk Main Business Overview
  13.3.5 Novo Nordisk Latest Developments
13.4 Takeda
  13.4.1 Takeda Company Information
  13.4.2 Takeda Blood Coagulants Product Portfolios and Specifications
  13.4.3 Takeda Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Takeda Main Business Overview
  13.4.5 Takeda Latest Developments
13.5 SOBI
  13.5.1 SOBI Company Information
  13.5.2 SOBI Blood Coagulants Product Portfolios and Specifications
  13.5.3 SOBI Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 SOBI Main Business Overview
  13.5.5 SOBI Latest Developments
13.6 Octapharma
  13.6.1 Octapharma Company Information
  13.6.2 Octapharma Blood Coagulants Product Portfolios and Specifications
  13.6.3 Octapharma Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Octapharma Main Business Overview
  13.6.5 Octapharma Latest Developments
13.7 CSL
  13.7.1 CSL Company Information
  13.7.2 CSL Blood Coagulants Product Portfolios and Specifications
  13.7.3 CSL Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 CSL Main Business Overview
  13.7.5 CSL Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Blood Coagulants Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Blood Coagulants Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Coagulation Factor
Table 4. Major Players of Plasma Coagulation Factor
Table 5. Global Blood Coagulants Sales by Type (2020-2025) & (K Units)
Table 6. Global Blood Coagulants Sales Market Share by Type (2020-2025)
Table 7. Global Blood Coagulants Revenue by Type (2020-2025) & ($ million)
Table 8. Global Blood Coagulants Revenue Market Share by Type (2020-2025)
Table 9. Global Blood Coagulants Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Blood Coagulants Sale by Sale Channel (2020-2025) & (K Units)
Table 11. Global Blood Coagulants Sale Market Share by Sale Channel (2020-2025)
Table 12. Global Blood Coagulants Revenue by Sale Channel (2020-2025) & ($ million)
Table 13. Global Blood Coagulants Revenue Market Share by Sale Channel (2020-2025)
Table 14. Global Blood Coagulants Sale Price by Sale Channel (2020-2025) & (USD/Unit)
Table 15. Global Blood Coagulants Sales by Company (2020-2025) & (K Units)
Table 16. Global Blood Coagulants Sales Market Share by Company (2020-2025)
Table 17. Global Blood Coagulants Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Blood Coagulants Revenue Market Share by Company (2020-2025)
Table 19. Global Blood Coagulants Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Blood Coagulants Producing Area Distribution and Sales Area
Table 21. Players Blood Coagulants Products Offered
Table 22. Blood Coagulants Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Blood Coagulants Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Blood Coagulants Sales Market Share Geographic Region (2020-2025)
Table 27. Global Blood Coagulants Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Blood Coagulants Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Blood Coagulants Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Blood Coagulants Sales Market Share by Country/Region (2020-2025)
Table 31. Global Blood Coagulants Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Blood Coagulants Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Blood Coagulants Sales by Country (2020-2025) & (K Units)
Table 34. Americas Blood Coagulants Sales Market Share by Country (2020-2025)
Table 35. Americas Blood Coagulants Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Blood Coagulants Sales by Type (2020-2025) & (K Units)
Table 37. Americas Blood Coagulants Sales by Sale Channel (2020-2025) & (K Units)
Table 38. APAC Blood Coagulants Sales by Region (2020-2025) & (K Units)
Table 39. APAC Blood Coagulants Sales Market Share by Region (2020-2025)
Table 40. APAC Blood Coagulants Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Blood Coagulants Sales by Type (2020-2025) & (K Units)
Table 42. APAC Blood Coagulants Sales by Sale Channel (2020-2025) & (K Units)
Table 43. Europe Blood Coagulants Sales by Country (2020-2025) & (K Units)
Table 44. Europe Blood Coagulants Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Blood Coagulants Sales by Type (2020-2025) & (K Units)
Table 46. Europe Blood Coagulants Sales by Sale Channel (2020-2025) & (K Units)
Table 47. Middle East & Africa Blood Coagulants Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Blood Coagulants Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Blood Coagulants Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Blood Coagulants Sales by Sale Channel (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Blood Coagulants
Table 52. Key Market Challenges & Risks of Blood Coagulants
Table 53. Key Industry Trends of Blood Coagulants
Table 54. Blood Coagulants Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Blood Coagulants Distributors List
Table 57. Blood Coagulants Customer List
Table 58. Global Blood Coagulants Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Blood Coagulants Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Blood Coagulants Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Blood Coagulants Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Blood Coagulants Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Blood Coagulants Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Blood Coagulants Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Blood Coagulants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Blood Coagulants Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Blood Coagulants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Blood Coagulants Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Blood Coagulants Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Blood Coagulants Sales Forecast by Sale Channel (2026-2031) & (K Units)
Table 71. Global Blood Coagulants Revenue Forecast by Sale Channel (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Blood Coagulants Product Portfolios and Specifications
Table 74. Pfizer Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Bayer Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Blood Coagulants Product Portfolios and Specifications
Table 79. Bayer Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. Novo Nordisk Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 83. Novo Nordisk Blood Coagulants Product Portfolios and Specifications
Table 84. Novo Nordisk Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Novo Nordisk Main Business
Table 86. Novo Nordisk Latest Developments
Table 87. Takeda Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 88. Takeda Blood Coagulants Product Portfolios and Specifications
Table 89. Takeda Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Takeda Main Business
Table 91. Takeda Latest Developments
Table 92. SOBI Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 93. SOBI Blood Coagulants Product Portfolios and Specifications
Table 94. SOBI Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. SOBI Main Business
Table 96. SOBI Latest Developments
Table 97. Octapharma Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 98. Octapharma Blood Coagulants Product Portfolios and Specifications
Table 99. Octapharma Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Octapharma Main Business
Table 101. Octapharma Latest Developments
Table 102. CSL Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Blood Coagulants Product Portfolios and Specifications
Table 104. CSL Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. CSL Main Business
Table 106. CSL Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Blood Coagulants
Figure 2. Blood Coagulants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Coagulants Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Blood Coagulants Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Blood Coagulants Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Blood Coagulants Sales Market Share by Country/Region (2024)
Figure 10. Blood Coagulants Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Coagulation Factor
Figure 12. Product Picture of Plasma Coagulation Factor
Figure 13. Global Blood Coagulants Sales Market Share by Type in 2025
Figure 14. Global Blood Coagulants Revenue Market Share by Type (2020-2025)
Figure 15. Blood Coagulants Consumed in Hospital
Figure 16. Global Blood Coagulants Market: Hospital (2020-2025) & (K Units)
Figure 17. Blood Coagulants Consumed in Pharmacy
Figure 18. Global Blood Coagulants Market: Pharmacy (2020-2025) & (K Units)
Figure 19. Blood Coagulants Consumed in Other
Figure 20. Global Blood Coagulants Market: Other (2020-2025) & (K Units)
Figure 21. Global Blood Coagulants Sale Market Share by Sale Channel (2024)
Figure 22. Global Blood Coagulants Revenue Market Share by Sale Channel in 2025
Figure 23. Blood Coagulants Sales by Company in 2025 (K Units)
Figure 24. Global Blood Coagulants Sales Market Share by Company in 2025
Figure 25. Blood Coagulants Revenue by Company in 2025 ($ millions)
Figure 26. Global Blood Coagulants Revenue Market Share by Company in 2025
Figure 27. Global Blood Coagulants Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Blood Coagulants Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Blood Coagulants Sales 2020-2025 (K Units)
Figure 30. Americas Blood Coagulants Revenue 2020-2025 ($ millions)
Figure 31. APAC Blood Coagulants Sales 2020-2025 (K Units)
Figure 32. APAC Blood Coagulants Revenue 2020-2025 ($ millions)
Figure 33. Europe Blood Coagulants Sales 2020-2025 (K Units)
Figure 34. Europe Blood Coagulants Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Blood Coagulants Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Blood Coagulants Revenue 2020-2025 ($ millions)
Figure 37. Americas Blood Coagulants Sales Market Share by Country in 2025
Figure 38. Americas Blood Coagulants Revenue Market Share by Country (2020-2025)
Figure 39. Americas Blood Coagulants Sales Market Share by Type (2020-2025)
Figure 40. Americas Blood Coagulants Sales Market Share by Sale Channel (2020-2025)
Figure 41. United States Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Blood Coagulants Sales Market Share by Region in 2025
Figure 46. APAC Blood Coagulants Revenue Market Share by Region (2020-2025)
Figure 47. APAC Blood Coagulants Sales Market Share by Type (2020-2025)
Figure 48. APAC Blood Coagulants Sales Market Share by Sale Channel (2020-2025)
Figure 49. China Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 53. India Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Blood Coagulants Sales Market Share by Country in 2025
Figure 57. Europe Blood Coagulants Revenue Market Share by Country (2020-2025)
Figure 58. Europe Blood Coagulants Sales Market Share by Type (2020-2025)
Figure 59. Europe Blood Coagulants Sales Market Share by Sale Channel (2020-2025)
Figure 60. Germany Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 61. France Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Blood Coagulants Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Blood Coagulants Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Blood Coagulants Sales Market Share by Sale Channel (2020-2025)
Figure 68. Egypt Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Blood Coagulants Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Blood Coagulants in 2025
Figure 74. Manufacturing Process Analysis of Blood Coagulants
Figure 75. Industry Chain Structure of Blood Coagulants
Figure 76. Channels of Distribution
Figure 77. Global Blood Coagulants Sales Market Forecast by Region (2026-2031)
Figure 78. Global Blood Coagulants Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Blood Coagulants Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Blood Coagulants Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Blood Coagulants Sales Market Share Forecast by Sale Channel (2026-2031)
Figure 82. Global Blood Coagulants Revenue Market Share Forecast by Sale Channel (2026-2031)